Simone Van der Star

Simone Van der Star


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2025 in Clinical Neuroradiology
Verified
Journal Article
Closed access
PDF file
BSBirgitta Snijders
Birgitta Snijders
LPLennard Pierey
Lennard Pierey
MPMike J.L. Peters
Mike J.L. Peters
SLStéphanie V. de Lange
Stéphanie V. de Lange
SSSimone Van der Star
Simone Van der Star
Huiberdina Lena KoekHuiberdina Lena Koek
Huiberdina Lena Koek

Verified
Journal Article
Open access
PDF file
SSSimone Van der Star
Simone Van der Star
Pim de JongPim de Jong
Pim de Jong
MKMadeleine Kok
Madeleine Kok
The purpose of our study is to determine a threshold for iodine quantification to distinguish definitely non-enhancing benign renal lesions from potential enhancing masses on portal venous dual-layer spectral computed tomography (CT) to reduce the need for additional multiphase CT. In this single-center retrospective study, patients (≥18 years) scanned between April 2021 and January 2023 following the local renal CT protocol were included. Exclusion criteria were patients without renal lesions, lesions smaller than 10 mm, only fat-containing lesions, abscesses or infarction, follow-up after radiofrequent ablation, wrong scan protocol, or artefacts. Scans were performed on a dual layer detector-based spectral CT (CT 7500, Philips Healthcare, Best, The Netherlands). Iodine concentration (mgI/mL) in renal lesions was determined using spectral data. Analyses were performed for all lesions and for lesions of >30 HU on portal venous CT. Enhancement on multiphase CT (≥20 ΔHU from true unenhanced (TUE) to portal venous phase (PVP) CT) was used as reference standard. To determine thresholds for iodine concentration receiver operating characteristic (ROC) curves, area under the curve (AUC) and 95% confidence intervals were calculated. To obtain thresholds for definite (non-)enhancement, 100% sensitivity with maximum specificity and 100% specificity with maximum sensitivity were noted. Data were measured using one reader. To assess interobserver agreement, a second reader performed measurements on the PVP CT scans. A total of 103 patients (62 years ± 14, 68 men) were included. We measured 328 renal lesions, 56 enhancing lesions (17%) in 38 patients and 272 non-enhancing lesions (83%) in 86 patients. The threshold for non-enhancing lesions was 0.76 mgI/mL or lower (100% sensitivity, 76% specificity). The threshold for a definite enhancing mass was 1.69 mgI/mL or higher (100% specificity, 78% sensitivity). A total of 77% of indeterminate lesions (>30 HU on PVP CT) in our study could be definitely characterized. Renal lesions can be definitively classified as non-enhancing or enhancing on PVP spectral CT using thresholds of 0.76 mgI/mL or 1.69 mgI/mL, respectively, eliminating the need for multiphase imaging.

4 September 2026 in European Journal of Radiology
Verified
Journal Article
Open access
SSSimone Van der Star
Simone Van der Star
PJP.A. de Jong
P.A. de Jong
JPJ.F. Prince
J.F. Prince
FWF.J. Wessels
F.J. Wessels
WFWouter Foppen
Wouter Foppen
MKM. Kok
M. Kok
To evaluate whether adding dual-layer spectral CT (DLCT) to conventional CT (CCT) improves diagnostic accuracy for acute bowel ischemia (ABI). This retrospective single-center study included 387 consecutive patients (61 ± 15 years; 42% female) who underwent biphasic abdominal DLCT for clinically suspected ABI. After testing interobserver agreement with an enriched sample of 25 scans (ĸ:0.41-0.68), the scans were divided into four batches and independently evaluated by four radiologists. Each scan was evaluated twice: first using CCT, then with added iodine density and 40 keV monoenergetic (monoE40) reconstructions. The presence of ABI was rated in accordance with our clinical practice on a five-point Likert scale. The reference standard was a composite of surgery, pathology, endoscopy, endovascular intervention, and/or clinical follow-up data. Diagnostic accuracy was calculated with 95% confidence intervals. Fifty-five patients (14%) had ABI, of whom 65% with surgical and/or pathological proof. The most common etiologies were arterial occlusion (44%) and non-occlusive mesenteric ischemia (33%). For CCT, sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 65% (95% CI 51-78), 93% (90-96), 61% (50-71), 94% (92-96), and 89% (86-92), respectively. Adding DLCT reconstructions did not improve sensitivity (65%), but had a limited improvement in the positive predictive value (61% to 67%) for monoE40 reconstruction (p = 0.046). Qualitative assessment of additional DLCT reconstructions (iodine density and monoE40) alongside CCT did not improve sensitivity for ABI diagnosis, but a small overall improvement in positive predictive value was observed for monoE40.